Canada Life’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,675
| Closed | -$295K | – | 2309 |
|
|
2023
Q1 | $295K | Sell |
1,675
-26
| -2% | -$4.58K | ﹤0.01% | 1813 |
|
|
2022
Q4 | $658K | Buy |
1,701
+84
| +5% | +$32.5K | ﹤0.01% | 1649 |
|
|
2022
Q3 | $545K | Buy |
1,617
+491
| +44% | +$165K | ﹤0.01% | 1664 |
|
|
2022
Q2 | $369K | Buy |
1,126
+124
| +12% | +$40.6K | ﹤0.01% | 1728 |
|
|
2022
Q1 | $449K | Hold |
1,002
| – | – | ﹤0.01% | 1736 |
|
|
2021
Q4 | $439K | Hold |
1,002
| – | – | ﹤0.01% | 1733 |
|
|
2021
Q3 | $560K | Hold |
1,002
| – | – | ﹤0.01% | 1707 |
|
|
2021
Q2 | $514K | Buy |
1,002
+904
| +922% | +$464K | ﹤0.01% | 1737 |
|
|
2021
Q1 | $76K | Hold |
98
| – | – | ﹤0.01% | 2172 |
|
|
2020
Q4 | $54K | Hold |
98
| – | – | ﹤0.01% | 2251 |
|
|
2020
Q3 | $45K | Hold |
98
| – | – | ﹤0.01% | 2207 |
|
|
2020
Q2 | $60K | Hold |
98
| – | – | ﹤0.01% | 2177 |
|
|
2020
Q1 | $47K | Hold |
98
| – | – | ﹤0.01% | 2147 |
|
|
2019
Q4 | $57K | Buy |
+98
| New | +$57K | ﹤0.01% | 2221 |
|
|
2019
Q3 | – | Sell |
-69
| Closed | -$54K | – | 2340 |
|
|
2019
Q2 | $54K | Sell |
69
-104
| -60% | -$81.4K | ﹤0.01% | 2421 |
|
|
2019
Q1 | $122K | Buy |
173
+98
| +131% | +$69.1K | ﹤0.01% | 2005 |
|
|
2018
Q4 | $34K | Hold |
75
| – | – | ﹤0.01% | 2475 |
|
|
2018
Q3 | $65K | Hold |
75
| – | – | ﹤0.01% | 2328 |
|
|
2018
Q2 | $52K | Hold |
75
| – | – | ﹤0.01% | 2398 |
|
|
2018
Q1 | $33K | Hold |
75
| – | – | ﹤0.01% | 2444 |
|
|
2017
Q4 | $33K | Hold |
75
| – | – | ﹤0.01% | 2442 |
|
|
2017
Q3 | $36K | Hold |
75
| – | – | ﹤0.01% | 2410 |
|
|
2017
Q2 | $41K | Buy |
+75
| New | +$41K | ﹤0.01% | 2376 |
|